Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Wearable Tens Device

Research Leaders

7 sponsors active, led by Ohio State University

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Early Phase 1 (1)

Trial Status

Recruiting2
Completed2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Wearable Tens Device1
  • Magnetogastrogram1
  • Urostim1
  • Inhaled Essential Oils1
  • Emeterm Wearable Tens Device1

Active Sponsors

  • Ohio State University2
  • National Center for Complementary and Integrative Health (NCCIH)1
  • Spaulding Rehabilitation Hospital1
  • Vanderbilt University Medical Center1
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top Investigators

Related Conditions

  • Postural Orthostatic Tachycardia Syndrome1
  • Chronic Nausea And Vomiting Syndrome1
  • Anxiety1
  • Diabetics Without Symptoms Of Gastroparesis1
  • Total Or Partial Gastrectomy1

Activity Timeline